Surmodics Inc. (SRDX)
NASDAQ: SRDX
· Real-Time Price · USD
27.85
0.03 (0.11%)
At close: May 14, 2025, 2:46 PM
Surmodics Revenue Breakdown
| Period Ending | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|
| Product Revenue | 73.59M | 60.61M | 54.62M | 46.48M | 44.32M | 40.22M | 37.95M |
| Product Revenue Growth | +21.41% | +10.97% | +17.52% | +4.88% | +10.19% | +5.97% | n/a |
| Research Development And Other Revenue | 10M | 9.57M | 9.08M | 11.6M | 9.91M | 11.4M | n/a |
| Research Development And Other Revenue Growth | +4.47% | +5.40% | -21.72% | +17.04% | -13.04% | n/a | n/a |
| Royalties Revenue | 42.49M | n/a | n/a | n/a | n/a | n/a | n/a |
| Royalties Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 15.04M | 15.17M | 14.58M | 16.63M | 13.09M | 12.54M | 12.81M | 12.87M | 12.97M | 13.24M | 13.78M | 12.85M | 11.11M | 9.19M | 7.87M | 7.88M | 7.91M | 7.02M | 7.3M | 7.42M | 6.73M | 6.94M | 7.19M | 5.94M | 4.88M | 5.95M | 6.5M | 5.98M | 6.44M | 5.19M | 5.31M | 5.23M | 5.08M | 4.86M | 5.01M | 4.48M | 4.85M | 3.61M | 6.18M | 4.02M | 4.13M |
| Selling, General, and Administrative Revenue Growth | -0.85% | +4.08% | -12.32% | +26.99% | +4.43% | -2.11% | -0.52% | -0.74% | -2.03% | -3.92% | +7.20% | +15.67% | +20.90% | +16.87% | -0.25% | -0.28% | +12.59% | -3.79% | -1.56% | +10.14% | -3.02% | -3.38% | +21.00% | +21.80% | -18.04% | -8.55% | +8.83% | -7.19% | +24.13% | -2.24% | +1.43% | +3.07% | +4.40% | -2.97% | +11.78% | -7.62% | +34.51% | -41.66% | +53.72% | -2.47% | n/a |
| Research and Development Revenue | 3.19M | 2.74M | 2.69M | 9.77M | 10.23M | 2.55M | 2.56M | 2.66M | 2.42M | 1.93M | 2.08M | 2.14M | 2.3M | 2.56M | 2.86M | 2.99M | 3.16M | 2.86M | 12.79M | 13.32M | 11.94M | 12.14M | 14.52M | 13.32M | 13.55M | 11.49M | 12.59M | 9.78M | 10.77M | 7.83M | 9.71M | 7.93M | 8.21M | 5.97M | 5.3M | 4.69M | 4.87M | 3.63M | 4.33M | 3.86M | 4.4M |
| Research and Development Revenue Growth | +16.24% | +2.05% | -72.50% | -4.54% | +301.77% | -0.39% | -4.02% | +10.09% | +25.08% | -7.20% | -2.62% | -6.88% | -10.23% | -10.52% | -4.41% | -5.28% | +10.45% | -77.63% | -4.03% | +11.64% | -1.70% | -16.39% | +9.02% | -1.73% | +18.01% | -8.78% | +28.77% | -9.24% | +37.58% | -19.38% | +22.53% | -3.42% | +37.49% | +12.58% | +13.00% | -3.59% | +33.96% | -16.00% | +12.07% | -12.33% | n/a |